---
title: "MEDICXI SECONDARY I LP — Ownership Dossier"
canonical: https://whiteintel.dev/entity/8a13639e-cf8b-585b-9d0c-9dd3a24663ac
json: https://whiteintel.dev/api/public/dossier/8a13639e-cf8b-585b-9d0c-9dd3a24663ac
identifier: sec:0001824997
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# MEDICXI SECONDARY I LP

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001824997`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/8a13639e-cf8b-585b-9d0c-9dd3a24663ac  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/8a13639e-cf8b-585b-9d0c-9dd3a24663ac  

## Ownership & control

### Holdings / subsidiaries

- **Centessa Pharmaceuticals plc** (tenpercentowner) — https://whiteintel.dev/entity/8043a488-3895-5c19-b9a5-372a51ca41d8

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **MEDICXI SECONDARY I LP**. Human view: https://whiteintel.dev/entity/8a13639e-cf8b-585b-9d0c-9dd3a24663ac · Structured JSON: https://whiteintel.dev/api/public/dossier/8a13639e-cf8b-585b-9d0c-9dd3a24663ac._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._